COVID-19感染后特异性丘脑血流减低
一例41岁女性在感染COVID-19后出现持续3周的完全性失眠且日间无困倦,SPECT显示双侧丘脑区域脑血流量显著减低,被诊断为与COVID-19感染相关的失眠伴丘脑低灌注;作者称这是首例区域脑血流减低特异局限于丘脑的病例。
要点
- 41岁女性感染COVID-19后出现持续3周的完全性失眠,日间无困倦。
- SPECT显示双侧丘脑区域脑血流量显著减低。
- 作者诊断为COVID-19感染相关的失眠伴丘脑低灌注。
核心结论
- 作者诊断该41岁女性为COVID-19感染相关的失眠伴丘脑低灌注。
- 作者称据其所知这是首例区域脑血流减低特异局限于丘脑的病例。
研究设计与样本
- 个案报告:一例41岁女性,感染COVID-19后出现持续3周的完全性失眠且日间无困倦,行SPECT检查。
主要发现
- SPECT使用N-异丙基-p-[123I]碘代安非他明显示双侧丘脑区域脑血流量显著减低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although long COVID refers to numerous COVID-19-related symptoms after infection, including depression, fatigue, anosmia, sleep disturbances, and brain fog, the etiology of long COVID remains largely unknown. A 41-year-old woman presented with a 3-week history of complete insomnia without drowsiness throughout the day after contracting COVID-19. SPECT using N -isopropyl-p-[ 123 I] iodoamphetamine showed a significant regional cerebral blood flow reduction in the bilateral thalamus. We diagnosed her as having insomnia accompanied by thalamic hypoperfusion related to COVID-19 infection. To our knowledge, this is the first case of reduced regional cerebral blood flow specifically confined to the thalamus.
引用
- Matsubayashi T, Yokoyama K, Tateishi U, et al. Specifically Decreased Thalamic Blood Flow Following COVID-19 Infection. Clin Nucl Med. 2024. PMID: 39354691. doi:10.1097/RLU.0000000000005478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。